ID26210A - Proses pemurnian turunan sefalosporin - Google Patents

Proses pemurnian turunan sefalosporin

Info

Publication number
ID26210A
ID26210A IDW20001932A ID20001932A ID26210A ID 26210 A ID26210 A ID 26210A ID W20001932 A IDW20001932 A ID W20001932A ID 20001932 A ID20001932 A ID 20001932A ID 26210 A ID26210 A ID 26210A
Authority
ID
Indonesia
Prior art keywords
purification
sefalosporin
cefixime
purification process
ceph
Prior art date
Application number
IDW20001932A
Other languages
English (en)
Indonesian (id)
Inventor
Martin Decristoford
Johannes Ludescher
Hubert Sturm
Werner Veit
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of ID26210A publication Critical patent/ID26210A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70—Sulfur atoms
    • C07D277/74—Sulfur atoms substituted by carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Peptides Or Proteins (AREA)
IDW20001932A 1998-04-02 1999-03-31 Proses pemurnian turunan sefalosporin ID26210A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0057598A AT406773B (de) 1998-04-02 1998-04-02 Neues salz von 7-(2-(aminothiazol-4yl)-2-

Publications (1)

Publication Number Publication Date
ID26210A true ID26210A (id) 2000-12-07

Family

ID=3494225

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001932A ID26210A (id) 1998-04-02 1999-03-31 Proses pemurnian turunan sefalosporin

Country Status (16)

Country Link
US (1) US6825345B2 (zh)
EP (1) EP1068211B1 (zh)
JP (1) JP2002510694A (zh)
KR (1) KR20010034671A (zh)
CN (1) CN1134447C (zh)
AT (2) AT406773B (zh)
AU (1) AU3603599A (zh)
BR (1) BR9909898A (zh)
CA (1) CA2326441C (zh)
DE (1) DE69937143T2 (zh)
ES (1) ES2293720T3 (zh)
HK (1) HK1034078A1 (zh)
ID (1) ID26210A (zh)
TR (1) TR200002838T2 (zh)
WO (1) WO1999051607A2 (zh)
ZA (1) ZA200004899B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT404727B (de) * 1997-01-16 1999-02-25 Biochemie Gmbh Kristallines salz von cefixim und verfahren zu dessen herstellung
ITMI20012364A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Processo di sintesi della cefixima via alchil-o arilsolfonati
WO2004046154A1 (en) * 2002-11-15 2004-06-03 Orchid Chemicals & Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
US7662955B2 (en) * 2003-03-20 2010-02-16 Orchid Chemicals And Pharmaceuticals Ltd. Process for the preparation of cefoxitin
MX2007007476A (es) * 2004-12-21 2007-08-15 Lupin Ltd Proceso para la preparacion de cefixima.
WO2006103686A1 (en) * 2005-03-29 2006-10-05 Hetero Drugs Limited An improved process for the preparation of cefixime
CN1312158C (zh) * 2005-05-20 2007-04-25 天津市医药集团技术发展有限公司 一种头孢克肟的制备方法
CN101812075B (zh) * 2010-05-07 2012-06-13 郝志艳 一种头孢克肟化合物及其新制法
CN103265562A (zh) * 2013-05-29 2013-08-28 四川方向药业有限责任公司 头孢克肟的制备方法
CN103965217A (zh) * 2014-05-21 2014-08-06 广州白云山制药股份有限公司广州白云山化学制药厂 3-三嗪环-7-（噻唑羧甲氧亚氨基）头孢烷酸的制备方法
CN103965216A (zh) * 2014-05-21 2014-08-06 广州白云山制药股份有限公司广州白云山化学制药厂 7-（噻唑羧甲氧亚氨基)- 3-三嗪环头孢化合物的制造方法
WO2016142902A1 (en) * 2015-03-11 2016-09-15 Lupin Limited Cefixime with reduced surface area and high stability

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA806977B (en) * 1979-11-19 1981-10-28 Fujisawa Pharmaceutical Co 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
JPS58986A (ja) * 1981-05-07 1983-01-06 Fujisawa Pharmaceut Co Ltd セフェム化合物
JPS57192392A (en) * 1981-05-19 1982-11-26 Sankyo Co Ltd Production of 3-alkoxymethylcephalosporin
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
DE3377061D1 (en) * 1982-06-03 1988-07-21 Hoffmann La Roche Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
EP0096296B1 (de) 1982-06-03 1987-07-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 1-Sulfo-2-oxoazetidinderivate
JPS59163387A (ja) * 1983-03-07 1984-09-14 Sankyo Co Ltd ３−アルコキシメチルセフアロスポリンの製造方法
JPH0692416B2 (ja) * 1985-03-13 1994-11-16 三共株式会社 セフアロスポラン酸誘導体
ES2042507T3 (es) * 1986-02-07 1993-12-16 Hoffmann La Roche Procedimiento para la obtencion de carboxiamidas.
US5359057A (en) 1986-02-07 1994-10-25 Hoffmann-La Roche Inc. Acylation of amines
JPH01242589A (ja) * 1988-03-22 1989-09-27 Fujisawa Pharmaceut Co Ltd セフエム化合物
KR950700311A (ko) * 1992-02-05 1995-01-16 게오르게스 그렐리니, 한스 루돌프하우스 3-세펨-4-카복실산 유도체의 정제방법(Process for the purification of a 3-cephem-4-carboxylic acid derivatives)
ATE198892T1 (de) * 1993-11-17 2001-02-15 Biochemie Gmbh Trennung von cephalosporinisomeren
AT403049B (de) * 1995-08-14 1997-10-27 Biochemie Gmbh Abreicherung von 7-adca in 3-vinyl-aca
AT404251B (de) * 1996-08-14 1998-10-27 Biochemie Gmbh Neues kristallines salz von cefixim
EP0831093A1 (en) * 1996-09-23 1998-03-25 F. Hoffmann-La Roche Ag 1-Carba-(dethia)-Cephalosporin Derivatives
TW538045B (en) * 1997-01-16 2003-06-21 Biochemie Gmbh Process for purifying cefixime

Also Published As

Publication number Publication date
ZA200004899B (en) 2001-12-24
HK1034078A1 (en) 2001-10-12
DE69937143D1 (de) 2007-10-31
BR9909898A (pt) 2000-12-26
DE69937143T2 (de) 2008-06-12
ATE373666T1 (de) 2007-10-15
EP1068211B1 (en) 2007-09-19
US6825345B2 (en) 2004-11-30
ATA57598A (de) 2000-01-15
AU3603599A (en) 1999-10-25
ES2293720T3 (es) 2008-03-16
JP2002510694A (ja) 2002-04-09
WO1999051607A2 (en) 1999-10-14
WO1999051607A3 (en) 2000-01-27
TR200002838T2 (tr) 2001-02-21
EP1068211A2 (en) 2001-01-17
CN1295576A (zh) 2001-05-16
CA2326441A1 (en) 1999-10-14
CN1134447C (zh) 2004-01-14
US20030208065A1 (en) 2003-11-06
AT406773B (de) 2000-08-25
KR20010034671A (ko) 2001-04-25
CA2326441C (en) 2008-03-18

Similar Documents

Publication Publication Date Title
NL350075I2 (zh)
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
BR9804214A (pt) Compostos.
MXPA04001323A (es) Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso.
ID26210A (id) Proses pemurnian turunan sefalosporin
FI98067B (fi) Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi
ATE353903T1 (de) Kristalline cefdinirsalze
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
HUP0302530A3 (en) Process for the purification of 2-nitro-4-methylsulphonylbenzoic acid
ATE46518T1 (de) Sialosylcerebroside und verfahren zu ihrer herstellung.
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
ID28144A (id) Proses pemurnian asam isoftalat melalui kristalisasi
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
DE50010234D1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
DE60033207D1 (de) Werkzeug zur herstellung von nockenwellen durch einwalzen
AP2000001760A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
BR0013751A (pt) Processo para produção de derivados de ácido naftiridina-3-carboxìlico
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
ID27440A (id) Proses untuk menyiapkan penengah-penengah
ATE269858T1 (de) Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartan
MY139289A (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
TR199902117T2 (xx) (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu.
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
MXPA04002640A (es) Esteres de analogos de 3-desoxi-vitamina d3.